Evidence map›Paper›PMID 33967549›Full record

ArticleJournal of clinical orthopaedics and trauma2021

Orthopaedic trauma during COVID-19: Is patient care compromised during a pandemic?

Brian D Batko, Jeremy Hreha, James S Potter, Luis Guinand, Mark C Reilly, Michael S Sirkin, Michael M Vosbikian, Mark R Adams

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical orthopaedics and trauma, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Outcomes of hip fracture surgery during the COVID-19 pandemic.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Brian D BatkoDepartment of Orthopaedic Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.
Jeremy HrehaDepartment of Orthopaedic Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.
James S PotterDepartment of Orthopaedic Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.
Luis GuinandDepartment of Orthopaedic Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.
Mark C ReillyDepartment of Orthopaedic Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.
Michael S SirkinDepartment of Orthopaedic Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.
Michael M VosbikianDepartment of Orthopaedic Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.
Mark R AdamsDepartment of Orthopaedic Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.
Rutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Coronavirus disease-2019 (COVID-19) placed unprecedented pressure on the healthcare system. Many institutions implemented a government-mandated restructured set of safety and administrative protocols to treat urgent orthopaedic trauma patients. The objective of this study was to compare two cohorts of patients, a COVID group and non-COVID control group, and to evaluate the effectiveness of safety measures outlined in the Rutgers Orthopaedic Trauma Patient Safety Protocol (ROTPSP). Secondary outcomes were to elucidate risk factors for complications associated with fractures and COVID-19.

methodsPatients treated for orthopaedic traumatic injuries were retrospectively identified between March and May 2020, and compared to a series of patients from the same time period in 2018. Main outcome measures included surgical site infections (SSI), length of stay (LOS), post-operative LOS (poLOS), presentation to OR time (PORT), and length of surgery.

resultsAfter review, 349 patients (201 non-COVID, 148 COVID) undergoing 426 surgeries were included. Average LOS (11.91 days vs. 9.27 days, p = 0.04), poLOS (9.68 days vs. 7.39 days, p = 0.03), and PORT (30.56 vs. 25.59 h, p < 0.01) was significantly shorter in the COVID cohort. There were less SSI in the COVID group (5) compared to the non-COVID group (14) (p = 0.03). Overall complications were significantly lower in the COVID group. Patients receiving Cepheid tests had significantly shorter LOS and poLOS compared to patients receiving the RNA and DiaSorin tests (p < 0.01 and p < 0.01, respectively). The Cepheid test carried the best benefit-to-cost ratio, 0.10, p < 0.05.

conclusionThe restructuring of care protocols caused by COVID-19 did not negatively impact perioperative complication rates, PORT or LOS. Cepheid COVID test type administered upon admission plays an integral role in a patient's hospital course by reducing both length of stay and hospital costs. This information demonstrates we can continue to treat orthopaedic trauma patients safely during the COVID-19 pandemic by utilizing strict safety protocols.

Indexed as

CepheidClinical outcomesOrthopaedic traumaPatient safety protocolsSurgical site infections

Identifiers

PMID33967549
PMCPMC8088543
OpenAlexW3158094806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.